These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22564284)

  • 41. Stroke prevention in patients with atrial fibrillation: focus on new oral anticoagulants.
    Toth PP
    Postgrad Med; 2013 May; 125(3):155-61. PubMed ID: 23748516
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cardioembolic stroke in atrial fibrillation and new anticoagulation criteria: a therapeutic dare].
    Perez-Ortega I; Moniche-Alvarez F; Jimenez-Hernandez MD; Gonzalez-Marcos JR
    Rev Neurol; 2012 Jul; 55(2):74-80. PubMed ID: 22760766
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stroke prophylaxis with warfarin or dabigatran for patients with non-valvular atrial fibrillation-cost analysis.
    Ali A; Bailey C; Abdelhafiz AH
    Age Ageing; 2012 Sep; 41(5):681-4. PubMed ID: 22378612
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dilemma of indication for thrombolysis in a patient with acute ischemic stroke treated with a novel oral anticoagulant.
    Folyovich A; Varga V; Béres-Molnár KA; Vadasdi K; Bereczki D
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):580-2. PubMed ID: 23721623
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. A Multicenter Inception Cohort Study.
    Pengo V; Legnani C; Noventa F; Palareti G;
    Thromb Haemost; 2001 Mar; 85(3):418-22. PubMed ID: 11307807
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]).
    Schwammenthal Y; Bornstein N; Schwammenthal E; Schwartz R; Goldbourt U; Tsabari R; Koton S; Grossman E; Tanne D
    Am J Cardiol; 2010 Feb; 105(3):411-6. PubMed ID: 20102959
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ineligibility for anticoagulation in patients with atrial fibrillation.
    del Conde I; Halperin JL
    Am J Med; 2013 Feb; 126(2):105-11. PubMed ID: 23331435
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy.
    Partington SL; Abid S; Teo K; Oczkowski W; O'Donnell MJ
    Thromb Res; 2007; 120(5):663-9. PubMed ID: 17434577
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Antithrombotic therapy in patients with first-ever stroke and known non-rheumatic atrial fibrillation].
    Gandjour J; Zeindler J; Georgiadis D; Baumgartner RW
    Praxis (Bern 1994); 2005 Jan; 94(4):97-104. PubMed ID: 15732803
    [TBL] [Abstract][Full Text] [Related]  

  • 50. INR variability in atrial fibrillation: a risk model for cerebrovascular events.
    Amouyel P; Mismetti P; Langkilde LK; Jasso-Mosqueda G; Nelander K; Lamarque H
    Eur J Intern Med; 2009 Jan; 20(1):63-9. PubMed ID: 19237095
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.
    Lee BH; Park JS; Park JH; Park JS; Kwak JJ; Hwang ES; Kim SK; Choi DH; Kim YH; Pak HN
    J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anticoagulation in patients with acute ischemic stroke and atrial fibrillation--a balance of risks and benefits.
    Beri A; Punnam SR
    Cardiovasc Drugs Ther; 2008 Oct; 22(5):419-25. PubMed ID: 18642133
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Stroke and atrial fibrillation].
    Gahn G
    Herzschrittmacherther Elektrophysiol; 2009 Jun; 20(2):70-2. PubMed ID: 19484179
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ischaemic stroke in patients treated with oral anticoagulants.
    Cano LM; Cardona P; Quesada H; Lara B; Rubio F
    Neurologia; 2016; 31(6):395-400. PubMed ID: 25529172
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early Anti-Coagulation after Ischemic Stroke due to Atrial Fibrillation is Safe and Prevents Recurrent Stroke.
    Hahn C; Hill MD
    Can J Neurol Sci; 2015 Mar; 42(2):92-5. PubMed ID: 25740380
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Obstructive sleep apnea and the risk of ischemic stroke in patients with atrial fibrillation.
    Chang CC; Chiu CC; Chiang CH; Huang CC; Chan WL; Huang PH; Chen YC; Chen TJ; Chung CM; Lin SJ; Chen JW; Leu HB
    Int J Cardiol; 2015 Feb; 181():144-6. PubMed ID: 25497540
    [No Abstract]   [Full Text] [Related]  

  • 57. Preventing stroke in patients with chronic kidney disease and atrial fibrillation: benefit and risks of old and new oral anticoagulants.
    Reinecke H; Engelbertz C; Schäbitz WR
    Stroke; 2013 Oct; 44(10):2935-41. PubMed ID: 24008579
    [No Abstract]   [Full Text] [Related]  

  • 58. From clinical trials to clinical practice: oral anticoagulation among patients with non-rheumatic, atrial fibrillation.
    Llop R; Ferrer A; Agustí A; Vidal X; Arnau JM; Laporte JR
    Eur J Clin Pharmacol; 1997; 53(1):1-5. PubMed ID: 9349922
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Direct oral anticoagulants in the early phase of non-valvular atrial fibrillation-related ischemic stroke in very old patients undergoing systemic thrombolysis and/or mechanical thrombectomy.
    Masotti L; Moroni F; Vannucchi V; Grifoni E; Dei A; Landini G
    Geriatr Gerontol Int; 2018 Aug; 18(8):1304-1305. PubMed ID: 30136389
    [No Abstract]   [Full Text] [Related]  

  • 60. Risk factors and treatment at recurrent stroke onset: results from the Recurrent Stroke Quality and Epidemiology (RESQUE) Study.
    Leoo T; Lindgren A; Petersson J; von Arbin M
    Cerebrovasc Dis; 2008; 25(3):254-60. PubMed ID: 18216468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.